Singapore News
-
ASLAN signs news commercialisation agreement with BioGenetics
Singapore | News | 0 Comment | 11 Mar, 2019
ASLAN Pharmaceuticals, a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for glo...Read more
-
Advent Access to join Stanford StartX community
Singapore | News | 0 Comment | 12 Mar, 2019
Advent Access (Advent), one of Singapore’s most innovative medtech companies, has announced that it has been selec...Read more
-
Singaporeans, Thais suffer from MGD symptoms regularly unaware of risk
Singapore | News | 0 Comment | 07 Mar, 2019
A new survey conducted by Johnson & Johnson Vision has revealed that a majority of Singaporeans (70%) and Thais (77%...Read more
-
Duke-NUS team reveals unknown mechanisms of zika infection
Singapore | News | 0 Comment | 05 Mar, 2019
Researchers at Duke-NUS Medical School and their colleagues have identified a surprising interaction between dengue and ...Read more
-
Only 37% of Women receive critical cancer tests, finds a survey
Singapore | News | 1 Comment | 05 Mar, 2019
The substantial majority of women in Singapore are failing to undertake critical cancer screening tests, according to a ...Read more
-
Smartfuture introduces Teleconsultation and Marketplace
Singapore | News | 0 Comment | 04 Mar, 2019
Smartfuture has recently announced the latest features to the Medcheck App - Teleconsultation and Marketplace. With thes...Read more
-
Omron Healthcare, iAPPS to provide health management serivces
Singapore | News | 0 Comment | 01 Mar, 2019
OMRON HEALTHCARE Co., Ltd. and iAPPS Pte. Ltd. have announced the establishment of HeartVoice Pte. Ltd., a joint venture...Read more
-
Tessa Therapeutics names Jeffrey H. Buchalter to Board of Directors
Singapore | News | 0 Comment | 01 Mar, 2019
Tessa Therapeutics, a clinical-stage immunotherapy company focused on autologous and off-the-shelf, allogeneic therapies...Read more
-
SCS, NCCS join hands to lead the fight against cancer
Singapore | News | 0 Comment | 27 Feb, 2019
Singapore Cancer Society (SCS) and the National Cancer Centre Singapore (NCCS) have inked a partnership that will provid...Read more
-
ASLAN pharma to partner with Biogenetics
Singapore | News | 0 Comment | 27 Feb, 2019
ASLAN Pharmaceuticals, a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for glo...Read more
-
SUSS signs two MOUs to help the elderly and their caregivers
Singapore | News | 0 Comment | 25 Feb, 2019
The Singapore University of Social Sciences (SUSS) signed two Memoranda of Understanding (MOUs) to collab...Read more
-
MSIWF puts focus on improving elderly welfare
Singapore | News | 0 Comment | 22 Feb, 2019
The spotlight was cast on the elderly and their caregivers as the Mitsui Sumitomo Insurance Welfare Foundation (“M...Read more
-
Doctor Anywhere unveils in-app marketplace
Singapore | News | 0 Comment | 21 Feb, 2019
Doctor Anywhere, a tech-led healthcare company, has launched Marketplace, an in-app e-commerce platform specially curate...Read more
-
Medix CEO Applauds Government’s ‘Merdeka Package’
Singapore | News | 0 Comment | 20 Feb, 2019
Sigal Atzmon, CEO of global medical case management company Medix, applauded the government's ‘Merdeka Generation ...Read more
-
Duke-NUS researchers link sleep schedule with cognition, glucose levels
Singapore | News | 0 Comment | 20 Feb, 2019
Researchers at Duke-NUS Medical School, Singapore have demonstrated for the first time that different sleep schedules wi...Read more
-
Dr James Allison & Dr Padmanee Sharma join Hummingbird Bioscience
Singapore | News | 0 Comment | 19 Feb, 2019
Hummingbird Bioscience, a systems-biology enabled biotech company focused on the discovery and development of cancer the...Read more
-
New breast cancer drug for women in Singapore
Singapore | News | 1 Comment | 19 Feb, 2019
A NEW breast cancer drug shown to significantly reduce the risk of cancer recurrence is being made available to women in...Read more
-
NCCS , Lucence predict immunotherapy response for kidney cancer
Singapore | News | 0 Comment | 18 Feb, 2019
Immunotherapy drugs such as PD-L1 checkpoint inhibitors represent the front-line treatment for kidney cancer. But immuno...Read more
